Vault-13

a16z Capital Management, L.L.C.

MENLO PARK, CA · CIK 1540358 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2019 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Menlo Park, CA (main office)United States United Statesabout 88
New York, NYUnited States United States
San Francisco, CAUnited States United States
Santa Monica, CAUnited States United States
Washington, DCUnited States United States

US visa salary filings

Job titleFilingsMedianRange
Director Of OperationsSan Francisco, CA 1 $280,000 $280,000 – $320,000
Portfolio Analytics & Reporting Manager, PerennialMenlo Park, CA 1 $215,000 $215,000 – $255,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: a16z Capital Management, L.L.C..

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$14.2bn reported value +1001.4% vs Q1 2026
19positions
99.4%in top 10
4 new 0 added 3 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPACE EXPLORATION TECHN CORP CLASS A COM STK SPCX SPCX 74,855,020 $12.8bn89.97% 89.97% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 74.9m
2 NAVAN INC CL A NAVN NAVN 28,218,676 $645.4m4.54% 4.54% UnchangedShares held: Q3 2025 0, Q4 2025 27.2m, Q1 2026 28.2m, Q2 2026 28.2m
3 REVOLUTION MEDICINES INC COM RVMD RVMD 921,099 $172.5m1.21% 1.21% UnchangedShares held: Q3 2025 2.7m, Q4 2025 921.1k, Q1 2026 921.1k, Q2 2026 921.1k
4 META PLATFORMS INC CL A META META 212,531 $119.7m0.84% 0.84% UnchangedShares held: Q3 2025 212.5k, Q4 2025 212.5k, Q1 2026 212.5k, Q2 2026 212.5k
5 FIGMA INC CLASS A COM STK FIG FIG 5,983,308 $108.2m0.76% 0.76% ReducedShares held: Q3 2025 16.2m, Q4 2025 16.2m, Q1 2026 16.0m, Q2 2026 6.0m -10.0m -10,028,070 -62.6%
6 BIOAGE LABS INC COM BIOA BIOA 3,233,170 $79.2m0.56% 0.56% UnchangedShares held: Q3 2025 3.2m, Q4 2025 3.2m, Q1 2026 3.2m, Q2 2026 3.2m
7 BLOCK INC CL A XYZ XYZ 1,016,697 $77.3m0.54% 0.54% UnchangedShares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 1.0m, Q2 2026 1.0m
8 ERASCA INC COM ERAS ERAS 2,862,500 $52.4m0.37% 0.37% UnchangedShares held: Q3 2025 2.9m, Q4 2025 2.9m, Q1 2026 2.9m, Q2 2026 2.9m
9 MAZE THERAPEUTICS INC COM MAZE MAZE 1,702,225 $50.8m0.36% 0.36% UnchangedShares held: Q3 2025 1.7m, Q4 2025 1.7m, Q1 2026 1.7m, Q2 2026 1.7m
10 DAMORA THERAPEUTICS INC COM NEW COM NEW 1,236,157 $32.2m0.23% 0.23% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.2m
11 OMADA HEALTH INC COM OMDA OMDA 1,153,639 $25.3m0.18% 0.18% ReducedShares held: Q3 2025 4.6m, Q4 2025 3.5m, Q1 2026 2.3m, Q2 2026 1.2m -1.2m -1,153,645 -50.0%
12 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 9,063,054 $16.9m0.12% 0.12% ReducedShares held: Q3 2025 17.7m, Q4 2025 17.7m, Q1 2026 17.7m, Q2 2026 9.1m -8.6m -8,590,863 -48.7%
13 ROBLOX CORP CL A RBLX RBLX 274,570 $14.9m0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 274.6k
14 AKTIS ONCOLOGY INC COM AKTS AKTS 415,000 $13.4m0.09% 0.09% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 415.0k, Q2 2026 415.0k
15 CAMP4 THERAPEUTICS CORP COM CAMP CAMP 2,125,339 $9.3m0.07% 0.07% UnchangedShares held: Q3 2025 2.1m, Q4 2025 2.1m, Q1 2026 2.1m, Q2 2026 2.1m
16 BITGO HOLDINGS INC COM SHS CL A BTGO BTGO 666,356 $3.5m0.02% 0.02% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 666.4k, Q2 2026 666.4k
17 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 140,000 $3.1m0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 140.0k
18 GINKGO BIOWORKS HOLDINGS INC CL A NEW DNA DNA 108,568 $1.1m0.01% 0.01% UnchangedShares held: Q3 2025 108.6k, Q4 2025 108.6k, Q1 2026 108.6k, Q2 2026 108.6k
19 IP STRATEGY HOLDINGS INC COM IPST IPST 4,137 $9.7k0.00% 0.00% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.1k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
IP STRATEGY HOLDINGS INC 82,740 $21.8k82.7k shares